The recruited TAMs further inhibit the proliferation and activity of CD8+ T cells, resulting in CRC progression.137 In some cases, the acetylation of oncoproteins could regulate both cancer stemness features and immune cell recruitment at the same time. The gene discussed is CD8A; the disease is cancer.